{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:25:05Z","timestamp":1791890705895,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ajog.2020.03.016","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T23:40:05Z","timestamp":1584574805000},"page":"525-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5088-5458","authenticated-orcid":false,"given":"Ioannis","family":"Bellos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Pergialiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Papapanagiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Loutradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Daskalakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2020.03.016_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/10641950601147945","article-title":"Population-based analysis of hypertensive disorders in pregnancy","volume":"26","author":"Lawler","year":"2007","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.03.016_bib2","doi-asserted-by":"crossref","first-page":"g2301","DOI":"10.1136\/bmj.g2301","article-title":"Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis","volume":"348","author":"Bramham","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.03.016_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/s-0036-1571318","article-title":"Rate of gestational diabetes mellitus and pregnancy outcomes in patients with chronic hypertension","volume":"33","author":"Leon","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2020.03.016_bib4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.semnephrol.2017.05.012","article-title":"New evidence in the management of chronic hypertension in pregnancy","volume":"37","author":"Podymow","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ajog.2020.03.016_bib5","doi-asserted-by":"crossref","first-page":"134.e1","DOI":"10.1016\/j.ajog.2011.10.878","article-title":"Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions","volume":"206","author":"Bateman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib6","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/0002-9378(93)90405-8","article-title":"Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone","volume":"169","author":"Duvekot","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib7","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib8","article-title":"Impact of antihypertensive treatment on maternal and perinatal outcomes in pregnancy complicated by chronic hypertension: a systematic review and meta-analysis","volume":"6","author":"Webster","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ajog.2020.03.016_bib9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14767058.2017.1390742","article-title":"Chronic hypertension: effect of blood pressure control on pregnancy outcome","volume":"32","author":"Panaitescu","year":"2019","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.03.016_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-Tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2020.03.016_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/GRF.0000000000000255","article-title":"Chronic hypertension in pregnancy: diagnosis, management, and outcomes","volume":"60","author":"Ankumah","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2020.03.016_bib13","author":"R\u00fccker"},{"key":"10.1016\/j.ajog.2020.03.016_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajog.2020.03.016_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.03.016_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2020.03.016_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.03.016_bib18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.ajog.2020.03.016_bib19","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V","article-title":"Explaining heterogeneity in meta-analysis: a comparison of methods","volume":"18","author":"Thompson","year":"1999","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.ajog.2020.03.016_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jrsm.1188","article-title":"The design-by-treatment interaction model: a unifying framework for modelling loop inconsistency in network meta-analysis","volume":"7","author":"Jackson","year":"2016","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ajog.2020.03.016_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ajog.2020.03.016_bib22","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.03.016_bib23","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.03.016_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2020.03.016_bib25","first-page":"634","article-title":"Clonidine hydrochloride: a safe and effective antihypertensive agent in pregnancy","volume":"66","author":"Horvath","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib26","doi-asserted-by":"crossref","first-page":"II129","DOI":"10.1161\/01.HYP.19.2_Suppl.II129","article-title":"Effectiveness of atenolol in the treatment of hypertension during pregnancy","volume":"19","author":"Fabregues","year":"1992","journal-title":"hypertension"},{"key":"10.1016\/j.ajog.2020.03.016_bib27","first-page":"427","article-title":"Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth","volume":"98","author":"Easterling","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib28","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/1471-0528.12428","article-title":"Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study","volume":"120","author":"Bateman","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.03.016_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/HJH.0000000000002256","article-title":"Neonatal effects of intrauterine metoprolol\/bisoprolol exposure during the second and third trimester","volume":"38","author":"Kayser","year":"2020","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ajog.2020.03.016_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001185","article-title":"\u03b2-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study","volume":"2","author":"Meidahl Petersen","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2020.03.016_bib31","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jch.13397","article-title":"Beta-blocker subtypes and risk of low birth weight in newborns","volume":"20","author":"Duan","year":"2018","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ajog.2020.03.016_bib32","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/HJH.0000000000001818","article-title":"Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort study","volume":"36","author":"Hoeltzenbein","year":"2018","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ajog.2020.03.016_bib33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/hr.2010.227","article-title":"Chronic hypertension with related drug treatment of pregnant women and congenital abnormalities in their offspring: a population-based study","volume":"34","author":"B\u00e1nhidy","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajog.2020.03.016_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.109.129098","article-title":"Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations","volume":"54","author":"Caton","year":"2009","journal-title":"Hypertens"},{"key":"10.1016\/j.ajog.2020.03.016_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.12891\/ceog1853.2015","article-title":"The effect of calcium channel blockers on prevention of preeclampsia in pregnant women with chronic hypertension","volume":"42","author":"Jiang","year":"2015","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/HYPERTENSIONAHA.117.09110","article-title":"Pregnancy outcome after first trimester use of methyldopa: a prospective cohort study","volume":"70","author":"Hoeltzenbein","year":"2017","journal-title":"Hypertens"},{"key":"10.1016\/j.ajog.2020.03.016_bib37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/M18-0338","article-title":"\u03b2-Blocker use in pregnancy and the risk for congenital malformations: an international cohort study","volume":"169","author":"Bateman","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2020.03.016_bib38","first-page":"489","article-title":"Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension","volume":"53","author":"Arias","year":"1979","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib39","first-page":"157","article-title":"Estudo comparativo com pindolol e metildopa em gestantes com hipertensao arterial cronica","volume":"98","author":"Freire","year":"1988","journal-title":"J\u00a0Bras Ginecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10641959009012940","article-title":"Effectiveness of antihypertensive drugs in the treatment of hypertension in pregnancy","volume":"9","author":"Voto","year":"1990","journal-title":"Clin Exp Hypertens Part B Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.03.016_bib41","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(97)06408-8","article-title":"Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia","volume":"350","author":"Steyn","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.03.016_bib42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(76)90597-3","article-title":"Fetal outcome in trial of antihypertensive treatment in pregnancy","volume":"2","author":"Redman","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2020.03.016_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-3782(77)90029-9","article-title":"Hypertension during pregnancy, with and without specific hypotensive treatment. I. Perinatal factors and neonatal morbidity","volume":"1","author":"Mutch","year":"1977","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2020.03.016_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/10641959609015702","article-title":"Effect of the beta-adrenergic blocker pindolol on platelet function in chronic hypertensive pregnancy","volume":"15","author":"Hirsch","year":"1996","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.03.016_bib45","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/bmj.286.6382.1927","article-title":"Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy","volume":"286","author":"Fidler","year":"1983","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/j.ajog.2020.03.016_bib46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/1471-0528.13569","article-title":"Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial","volume":"123","author":"Magee","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.03.016_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preghy.2019.05.009","article-title":"Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial","volume":"17","author":"Salama","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.03.016_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0020-7292(87)90181-0","article-title":"Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study","volume":"25","author":"Weitz","year":"1987","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2020.03.016_bib49","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0002-9378(90)91297-P","article-title":"A\u00a0comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy","volume":"162","author":"Sibai","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib50","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1471-0528.1998.tb10201.x","article-title":"Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza","volume":"105","author":"Parazzini","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.03.016_bib51","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bmj.301.6752.587","article-title":"Atenolol in essential hypertension during pregnancy","volume":"301","author":"Butters","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2020.03.016_bib52","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3109\/14767058.2013.852180","article-title":"Management of chronic hypertension during pregnancy with furosemide, amlodipine or aspirin: a pilot clinical trial","volume":"27","author":"Vigil-De Gracia","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2020.03.016_bib53","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/HYPERTENSIONAHA.117.09972","article-title":"Labetalol versus nifedipine as antihypertensive treatment for chronic hypertension in pregnancy: a randomized controlled trial","volume":"70","author":"Webster","year":"2017","journal-title":"Hypertens"},{"key":"10.1016\/j.ajog.2020.03.016_bib54","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0002-9149(97)00163-X","article-title":"Effect of atenolol on birth weight","volume":"79","author":"Lip","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajog.2020.03.016_bib55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-7061(99)00031-X","article-title":"Atenolol and fetal growth in pregnancies complicated by hypertension","volume":"12","author":"Lydakis","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2020.03.016_bib56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00006250-198602000-00008","article-title":"Chronic hypertension in pregnancy","volume":"67","author":"Mabie","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib57","article-title":"Safety of amlodipine in early pregnancy","volume":"8","author":"Mito","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ajog.2020.03.016_bib58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1081\/PRG-120013785","article-title":"Anti-hypertensive drugs in pregnancy and fetal growth: evidence for \u201cpharmacological programming\u201d in the first trimester?","volume":"21","author":"Bayliss","year":"2002","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2020.03.016_bib59","doi-asserted-by":"crossref","first-page":"301.e1","DOI":"10.1016\/j.ajog.2012.11.011","article-title":"Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes","volume":"208","author":"Orbach","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejogrb.2014.01.019","article-title":"Association between labetalol use for hypertension in pregnancy and adverse infant outcomes","volume":"175","author":"Xie","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2020.03.016_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1471-0528.13463","article-title":"Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis","volume":"123","author":"Shekhar","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2020.03.016_bib62","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.preghy.2018.08.426","article-title":"Nadolol use in pregnancy and small for gestational age (SGA) newborns at term: a case series","volume":"13","author":"Basso","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2020.03.016_bib63","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1253\/circj.CJ-15-0617","article-title":"Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease","volume":"80","author":"Tanaka","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.ajog.2020.03.016_bib64","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/AOG.0b013e31820cab69","article-title":"Effect of maternal heart disease on fetal growth","volume":"117","author":"Gelson","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2020.03.016_bib65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ogrm.2010.05.001","article-title":"Drugs acting on the pregnant uterus","volume":"20","author":"Arrowsmith","year":"2010","journal-title":"Obstet Gynaecol Reprod Med"},{"key":"10.1016\/j.ajog.2020.03.016_bib66","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.111.00833","article-title":"The risk of congenital malformations associated with exposure to \u03b2-blockers early in pregnancy: a meta-analysis","volume":"62","author":"Yakoob","year":"2013","journal-title":"Hypertens"},{"key":"10.1016\/j.ajog.2020.03.016_bib67","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"10","author":"Abalos","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2020.03.016_bib68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820303380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937820303380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:28:54Z","timestamp":1757590134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937820303380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0002937820303380"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2020.03.016","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2020.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}